$4.54
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Cytek Biosciences Opens Innovation Center in Washington
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
Overview
52-week range
$2.90
$6.18
50% of range
Avg surprise (last 3)
-39.5%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
86%
EM ±9.5% · $5 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.15 | $-0.11 | -36.4% | -66.7% | -0.4% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $-0.04 | $-0.07 | +42.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.09 | $-0.04 | -125.0% | — | +1.6% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | -$0.06 | -$0.04 | -50.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $52M | $47M |
| Cost of revenue | $23M | — | $25M | $22M | $21M | — | $22M | $21M |
| Gross profit | $21M | — | $28M | $24M | $20M | — | $29M | $25M |
| Operating income | $-18M | — | $-9M | $-11M | $-15M | — | $-4M | $-9M |
| Net income | $-19M | — | — | — | $-11M | — | — | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $66M | $91M | $93M | $75M | $95M | $99M | $162M | $178M |
| Inventory | $50M | $48M | $52M | $49M | $45M | $44M | $47M | $50M |
| Total current assets | $379M | $392M | $388M | $383M | $381M | $396M | $390M | $384M |
| Total assets | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $121M | $120M | $116M | $116M | $103M | $104M | $106M | $95M |
| Total equity | $328M | $342M | $379M | $378M | $380M | $396M | $385M | $389M |